Positive Pulse: Breaking News in HIV Management

Faculty

Needs Statement

Although substantial progress has been made in terms of the development of antiretroviral therapies and making them available to patients with HIV, many challenges remain in terms of when to initiate therapy and whom to treat. In addition, the efficacy and safety of new therapies, the role of ART in the prevention of HIV infection, and HIV/TB co-infection are of great concern and are at the center of significant research.  The Positive Pulse newsletter series provides clinicians with reports and clinical commentaries on the most significant data presented on these issues and others at major medical meetings throughout the year. In this issue of Positive Pulse: Expert Commentaries from IAS 2009, clinical experts will review data presented at the IAS meeting in South Africa on the benefits of earlier initiation of ART, HIV and TB epidemics, improved prevention of mother-to-child transmission of HIV, the role of ART as prevention refining ART options, promising results with new integrase inhibitors in development, conflicting data on NRTI exposure and CVD risk and evaluating ART in women and racial minorities

Target Audience

This activity is designed for health care practitioners (physicians, physician assistants, nurse practitioners, registered nurses) involved in the management of HIV patients.

Objectives

1. Identify recent developments in the field of HIV research, including epidemiology, transmission, access to care, and updates to treatment guidelines;
2. Analyze the latest data from clinical trials regarding the use of existing and novel antiretroviral agents for the treatment of naïve and experienced patients with HIV, including strategies to overcome drug resistance;
3. Develop and implement strategies with which to integrate the latest treatment data, as well as new information regarding drug toxicities and comorbidities into the whole health care of patients with HIV.

Accreditation

CME
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and HealthmattersCME. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

CNE
The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC).

The Kentucky Board of Nursing (KBN) approves The University of Kentucky College of Nursing (UKCON) as a provider. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. This educational activity is offered for a maximum of 1.00 ANCC and 1.2 KBN contact hour(s) for nurses who complete the entire program. Provider #: 3-0008-01-13-113. Certificates may be printed once the program is completed.

University of Kentucky College of Nursing is a provider approved by the California Board of Registered Nursing, Provider 00340864.

Faculty Disclosure

Dr. Hodder has the following to disclose:
Speakers Bureau: Bristol-Myers Squibb
Contract Research Support: Bristol-Myers Squibb, Gilead Sciences, Pfizer Inc, Tibotec
Consultant: Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Tibotec
Spouse’s Financial Interest: Retired Merck employee

Dr. Sax has the following to disclose:
Consultant: Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Tibotec
Teaching Honoraria: Abbott, Bristol-Myers Squibb, Gilead Sciences, Merck, Tibotec

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and HealthmattersCME. Supported by an unrestricted educational grant from Gilead Sciences Medical Affairs and Bristol-Myers Squibb.